TY  - JOUR
AU  - Anguita-Ruiz, Augusto
AU  - Pastor-Villaescusa, Belen
AU  - Leis, Rosaura
AU  - Bueno, Gloria
AU  - Hoyos, Raul
AU  - Vazquez-Cobela, Rocio
AU  - Latorre-Millan, Miriam
AU  - Cañete, M Dolores
AU  - Caballero-Villarraso, Javier
AU  - Gil, Angel
AU  - Cañete, Ramon
AU  - Aguilera, Concepcion M
PY  - 2019
DO  - 10.3390/jcm8091471
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/14511
T2  - Journal of clinical medicine
AB  - Metformin is a first-line oral antidiabetic agent that has shown additional effects in treating obesity and metabolic syndrome. Inter-individual variability in metformin response could be partially explained by the genetic component. Here, we aimed to...
LA  - en
PB  - MDPI
KW  - SNP
KW  - Clinical trials
KW  - Metformin
KW  - Obesity
KW  - Pediatrics
KW  - Pharmacogenetics
KW  - Hypoglycemic agents
KW  - Metformin
KW  - Body mass index
KW  - Pediatric obesity
KW  - Metabolic syndrome
KW  - Pharmacogenetics
KW  - Genotype
KW  - Lipids
TI  - Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial.
TY  - research article
VL  - 8
ER  -